Earlier analyses supported this association, reporting a stronger relationship between smoking and PBC (pooled OR: 1.67
The findings The researchers found: Self-reported daily cannabis use was more common among patients with first episode psychosis, compared to controls - 29.5% (or 266 out of 901) of patients versus 6.8% (84/1,237) of controls High-potency cannabis use was also more common among patients with first episode psychosis, compared to controls - 37.1% (334/901) versus 19.4% (240/1,237) Across the 11 sites, people who used cannabis on a daily basis were three times more likely to have a diagnosis of first episode psychosis, compared with people who had never used cannabis This increased to five times more likely for daily use of high potency cannabis There was no evidence of an association between less than-weekly cannabis use and psychosis, regardless of potency The authors estimate that one in five new cases (20.4%) of psychosis across the 11 sites may be linked to daily cannabis use, and one in ten (12.2%) linked to use of high potency cannabis
It also clearly debunks the theory that e-cigarettes act as a gateway to smoking
They also come in many styles, flavors, and strengths
In our model, the increase in PGC1 expression together with the maintained mitochondrial membrane potential suggests that chronic WCSE exposure promotes both mitochondrial and antioxidant adaptations
